Daniel-Issakani S - Search Results

1

A class of small molecules that inhibit TNFalpha-induced survival and death pathways via prevention of interactions between TNFalphaRI, TRADD, and RIP1.

Gururaja TL, Yung S, Ding R, Huang J, Zhou X, McLaughlin J, Daniel-Issakani S, Singh R, Cooper RD, Payan DG, Masuda ES, Kinoshita T. Gururaja TL, et al. Among authors: daniel issakani s. Chem Biol. 2007 Oct;14(10):1105-18. doi: 10.1016/j.chembiol.2007.08.012. Chem Biol. 2007. PMID: 17961823

2

Identification and functional characterization of a novel human misshapen/Nck interacting kinase-related kinase, hMINK beta.

Hu Y, Leo C, Yu S, Huang BC, Wang H, Shen M, Luo Y, Daniel-Issakani S, Payan DG, Xu X. Hu Y, et al. Among authors: daniel issakani s. J Biol Chem. 2004 Dec 24;279(52):54387-97. doi: 10.1074/jbc.M404497200. Epub 2004 Oct 6. J Biol Chem. 2004. PMID: 15469942 Free article.

3

A novel E3 ubiquitin ligase TRAC-1 positively regulates T cell activation.

Zhao H, Li CC, Pardo J, Chu PC, Liao CX, Huang J, Dong JG, Zhou X, Huang Q, Huang B, Bennett MK, Molineaux SM, Lu H, Daniel-Issakani S, Payan DG, Masuda ES. Zhao H, et al. Among authors: daniel issakani s. J Immunol. 2005 May 1;174(9):5288-97. doi: 10.4049/jimmunol.174.9.5288. J Immunol. 2005. PMID: 15843525

4

A homogeneous FRET assay system for multiubiquitin chain assembly and disassembly.

Gururaja TL, Pray TR, Lowe R, Dong G, Huang J, Daniel-Issakani S, Payan DG. Gururaja TL, et al. Among authors: daniel issakani s. Methods Enzymol. 2005;399:663-82. doi: 10.1016/S0076-6879(05)99044-7. Methods Enzymol. 2005. PMID: 16338388

5

R-253 disrupts microtubule networks in multiple tumor cell lines.

Gururaja TL, Goff D, Kinoshita T, Goldstein E, Yung S, McLaughlin J, Pali E, Huang J, Singh R, Daniel-Issakani S, Hitoshi Y, Cooper RD, Payan DG. Gururaja TL, et al. Among authors: daniel issakani s. Clin Cancer Res. 2006 Jun 15;12(12):3831-42. doi: 10.1158/1078-0432.CCR-06-0168. Clin Cancer Res. 2006. PMID: 16778111

6

Substrate modification with lysine 63-linked ubiquitin chains through the UBC13-UEV1A ubiquitin-conjugating enzyme.

Petroski MD, Zhou X, Dong G, Daniel-Issakani S, Payan DG, Huang J. Petroski MD, et al. Among authors: daniel issakani s. J Biol Chem. 2007 Oct 12;282(41):29936-45. doi: 10.1074/jbc.M703911200. Epub 2007 Aug 20. J Biol Chem. 2007. PMID: 17709375 Free article.

7

The poxvirus p28 virulence factor is an E3 ubiquitin ligase.

Huang J, Huang Q, Zhou X, Shen MM, Yen A, Yu SX, Dong G, Qu K, Huang P, Anderson EM, Daniel-Issakani S, Buller RM, Payan DG, Lu HH. Huang J, et al. Among authors: daniel issakani s. J Biol Chem. 2004 Dec 24;279(52):54110-6. doi: 10.1074/jbc.M410583200. Epub 2004 Oct 20. J Biol Chem. 2004. PMID: 15496420 Free article.

8

High-throughput screening for inhibitors of the e3 ubiquitin ligase APC.

Huang J, Sheung J, Dong G, Coquilla C, Daniel-Issakani S, Payan DG. Huang J, et al. Among authors: daniel issakani s. Methods Enzymol. 2005;399:740-54. doi: 10.1016/S0076-6879(05)99049-6. Methods Enzymol. 2005. PMID: 16338393

9

Approaches to discovering drugs that regulate E3 ubiquitin ligases.

Huang J, Tsvetkov L, Qu K, Daniel-Issakani S, Payan DG. Huang J, et al. Among authors: daniel issakani s. Ernst Schering Found Symp Proc. 2008;(1):153-70. doi: 10.1007/2789_2008_107. Ernst Schering Found Symp Proc. 2008. PMID: 19198069

10

A chemiluminescent microtiter plate assay for sensitive detection of protein kinase activity.

Lehel C, Daniel-Issakani S, Brasseur M, Strulovici B. Lehel C, et al. Anal Biochem. 1997 Jan 15;244(2):340-6. doi: 10.1006/abio.1996.9894. Anal Biochem. 1997. PMID: 9025951

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page